Ocular Therapeutics, Pharmacology and Emerging Treatments

Ocular therapeutics continues to develop through advances in pharmacology, targeted drug delivery, biologics, and innovative treatment strategies. This session will examine therapeutic approaches for retinal diseases, glaucoma, ocular surface disorders, inflammatory eye conditions, and other ophthalmic disorders. Discussions may include intravitreal treatments, sustained-release drug delivery systems, topical formulations, biologic therapies, gene-based treatments, and regenerative approaches. Attention will be given to treatment effectiveness, safety, tolerability, adherence, and access to therapies. The session will also explore emerging clinical research and the role of individualized treatment strategies in improving patient outcomes. Collaboration between clinicians, pharmacologists, researchers, and pharmaceutical professionals will be encouraged to support the development of new therapeutic options.

 

    Related Conference of Ocular Therapeutics, Pharmacology and Emerging Treatments

    December 03-04, 2026

    9th International Eye and Vision Congress

    Madrid, Spain
    March 25-26, 2027

    41st European Ophthalmology Congress

    Paris, France
    April 12-13, 2027

    26th Global Ophthalmologists Annual Meeting

    Dubai, UAE
    April 28-29, 2027

    4th International Conference on Ophthalmology

    Paris, France

    Ocular Therapeutics, Pharmacology and Emerging Treatments Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in